Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)-H-C-783-A31-75: EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed e...
Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)-H-C-783-A31-75: EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed e...
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)-H-C-783-A31-75: EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed e...
Stärke
Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)-H-C-783-A31-75: EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed e...
Packungsgröße
Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)-H-C-783-A31-75: EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed e...
Form
Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop)-H-C-783-A31-75: EPAR - Scientific conclusions, grounds for variation to the terms of the marketing authorisations and detailed e...
Sicherheitsprofil
Kontraindikationen
Nebenwirkungen
Scanne diesen QR-Code, um schnell auf diese Seite auf deinem Mobilgerät zuzugreifen.